CClinicalTrials.gg
Status unknownNCT02387411Updated Mar 13, 2015

High-intensity Interval Versus Combined Exercise Training in CHF

An interventional study of High-intensity interval exercise training and Combined exercise training in Heart Failure, sponsored by University of Athens. Status unknown at 1 site in Greece. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2015-03-13.

Sponsored by University of Athens · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Mar 2015), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Chronic heart failure (CHF) is a clinical syndrome presented with central, cardiac deterioration as well as peripheral vascular and muscular abnormalities, resulting finally to reduced exercise tolerance, quality of life and mortality rates. Exercise training is a major component of rehabilitation / secondary prevention interventions, inducing significant beneficial changes in mechanisms of pathophysiology, exercise tolerance, functional capacity and quality of life, while a positive impact on hospitalization and mortality reduction should not be also excluded. There has been growing interest in the characteristics and modalities of exercise training able to induce optimal benefits. High intensity and interval mode have been shown to induce greater benefits than moderate intensity and continuous mode regimes. Additionally, there has been sound rationale for the inclusion of strength training, which has been also shown able to yield benefits in terms of exercise capacity and quality of life. However, there haven't been much data on the so called combined regimes, which include both aerobic exercise and strength training. This study aims at investigating the effects of combined high-intensity interval and strength training compared to high-intensity interval exercise alone in CHF.

02

Conditions studied

  • Heart Failure

Browse trials for

Keywords

  • heart failure
  • aerobic exercise
  • strength training
  • cardiopulmonary rehabilitation
  • high-intensity exercise training
03

In context

Heart Failure

5,701 studies on the registry are indexed under Heart Failure; 1,220 are open to participants now.

This study's planned enrollment of 30 is below the median of 72 across 3,736 interventional studies indexed under Heart Failure.

Browse Heart Failure studies →

Lead sponsor

University of Athens is the lead sponsor of 133 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • stable heart failure
  • ejection fraction \<=45%
  • optimal medical treatment
  • NYHA class \<=III

Exclusion criteria

Exclusion Criteria:

  • contraindications for maximal cardiopulmonary exercise testing (CPET)
  • moderate to severe COPD
  • inability to follow exercise programs due to orthopaedic problems
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Active comparator
    Interval group

    high-intensity interval exercise training

    Other: High-intensity interval exercise training

  • Active comparator
    Combined group

    combined exercise training

    Other: Combined exercise training

Interventions

  • OtherHigh-intensity interval exercise training

    High-intensity interval exercise training \[4 reps \* (4 min at 80% VO2peak + 3 min at 50% VO2peak)\]

  • OtherCombined exercise training

    High intensity \[2 reps \* (4 min at 80% VO2peak + 3 min at 50% VO2peak)\] and strength exercise training (2-4 sets, 10-12 reps, 60-65% 1RM, for quadriceps and hamstrings, 14 min in total)

06

What researchers measure

Primary outcomes

  1. aerobic exercise capacity (assessed by cardiopulmonary exercise testing)

    Time frame: 3 months

Secondary outcomes

  1. strength exercise capacity (assessed by 1-repetition maximum test)

    Time frame: 3 months

  2. quality of life (assessed by MLWHF questionnaire)

    Time frame: 3 months

  3. quadriceps local adaptations (assessed by muscle biopsies)

    Time frame: 3 months

  4. quadriceps cross sectional area (assessed by CT)

    Time frame: 3 months

07

Study locations

1 site
  • Cardiopulmonary Exercise Testing & Rehabilitation Laboratory, 1st Critical Care Dpt, School of Medicine, University of Athens
    Athens, 10675, Greece
08

References and documents

Publications

  • Tryfonos A, Tzanis G, Pitsolis T, Karatzanos E, Koutsilieris M, Nanas S, Philippou A. Exercise Training Enhances Angiogenesis-Related Gene Responses in Skeletal Muscle of Patients with Chronic Heart Failure. Cells. 2021 Jul 28;10(8):1915. doi: 10.3390/cells10081915. PubMed 34440684 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 13, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02387411
Lead sponsor
University of Athens
Responsible party
Serafim Nanas (Prof Critical Care Medicine, University of Athens) — Principal investigator
First posted
Mar 13, 2015
Start date
May 2010
Primary completion
Jun 2015 (estimated)
Completion
Jun 2015 (estimated)
Last update
Mar 13, 2015

Study contacts

Serafim Nanas, MD, Prof.
study chair · Cardiopulmonary Exercise Testing & Rehabilitation Laboratory, 1st Critical Care Dpt, School of Medicine, University of Athens, Greece

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion